189 related articles for article (PubMed ID: 17006006)
21. Trends in HIV/AIDS diagnoses--33 states, 2001-2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(45):1149-53. PubMed ID: 16292247
[TBL] [Abstract][Full Text] [Related]
22. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.
Burgoyne RW; Tan DH
J Antimicrob Chemother; 2008 Mar; 61(3):469-73. PubMed ID: 18174196
[TBL] [Abstract][Full Text] [Related]
23. Impact of HAART therapy on co-infection of tuberculosis and HIV cases for 9 years in Taiwan.
Tseng SH; Jiang DD; Hoi HS; Yang SL; Hwang KP
Am J Trop Med Hyg; 2009 Apr; 80(4):675-7. PubMed ID: 19346398
[TBL] [Abstract][Full Text] [Related]
24. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
[TBL] [Abstract][Full Text] [Related]
25. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
26. HIV in older adults.
Simone MJ; Appelbaum J
Geriatrics; 2008 Dec; 63(12):6-12. PubMed ID: 19061274
[TBL] [Abstract][Full Text] [Related]
27. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
[TBL] [Abstract][Full Text] [Related]
28. Changes in mortality following HIV and AIDS and estimation of the number of people living with diagnosed HIV/AIDS in Australia, 1981-2003.
Nakhaee F; Black D; Wand H; McDonald A; Law M
Sex Health; 2009 Jun; 6(2):129-34. PubMed ID: 19457292
[TBL] [Abstract][Full Text] [Related]
29. [Clinical and basic researches on HIV/AIDS].
Cao YZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):609-12. PubMed ID: 17121215
[TBL] [Abstract][Full Text] [Related]
30. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
[TBL] [Abstract][Full Text] [Related]
31. Socio-economic impact of antiretroviral treatment in HIV patients. An economic review of cost savings after introduction of HAART.
Gonzalo T; García Goñi M; Muñoz-Fernández MA
AIDS Rev; 2009; 11(2):79-90. PubMed ID: 19529748
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of human immunodeficiency virus-infected and -exposed children undergoing surgery--a prospective study.
Karpelowsky JS; Leva E; Kelley B; Numanoglu A; Rode H; Millar AJ
J Pediatr Surg; 2009 Apr; 44(4):681-7. PubMed ID: 19361626
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
[TBL] [Abstract][Full Text] [Related]
34. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy.
Venkat A; Piontkowsky DM; Cooney RR; Srivastava AK; Suares GA; Heidelberger CP
Ann Emerg Med; 2008 Sep; 52(3):274-85. PubMed ID: 18358567
[TBL] [Abstract][Full Text] [Related]
35. [The HIV/AIDS epidemic in the Province of Sassari in the combination antiretroviral therapy era].
Madeddu G; Calia GM; Lovigu C; Mannazzu M; Maida I; Babudieri S; Rezza G; Mura MS
Ann Ist Super Sanita; 2006; 42(2):197-202. PubMed ID: 17033141
[TBL] [Abstract][Full Text] [Related]
36. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
[TBL] [Abstract][Full Text] [Related]
37. Long-Term suppression of HIV infection: benefits and limitations of current treatment options.
Sension MG
J Assoc Nurses AIDS Care; 2007; 18(1 Suppl):S2-10. PubMed ID: 17275719
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus in correctional facilities: a review.
Spaulding A; Stephenson B; Macalino G; Ruby W; Clarke JG; Flanigan TP
Clin Infect Dis; 2002 Aug; 35(3):305-12. PubMed ID: 12115097
[TBL] [Abstract][Full Text] [Related]
39. The oncology impact of highly active antiretroviral therapy.
Schlichemeyer R; Chambers C; Gill MJ
J Oncol Pharm Pract; 2007 Mar; 13(1):17-25. PubMed ID: 17621563
[TBL] [Abstract][Full Text] [Related]
40. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Pinheiro Edos S; Antunes OA; Fortunak JM
Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
